ALBHF (Alibaba Health Information Technology) PB Ratio: 2.62 (As of Jul. 01, 2026) — 78% Below Median


ALBHF Alibaba Health Information Technology Ltd ALBHF
55 GF Score
Price $0.42
GF Value $0.70
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Alibaba Health Information Technology PB Ratio?

Alibaba Health Information Technology ALBHF +1.76% 55 PB Ratio is 2.62 as of Jul. 01, 2026, which is 78% below its 10-year median of 11.99. GuruFocus rates ALBHF with a GF Score™ of 55/100 and a GF Value™ of $0.70 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 608 Healthcare Providers & Services companies, Alibaba Health Information Technology ranks worse than 58.72% on this metric.

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-01), Alibaba Health Information Technology's share price is $0.42112. Alibaba Health Information Technology's Book Value per Share for the quarter that ended in Mar. 2026 was $0.16. Hence, Alibaba Health Information Technology's PB Ratio of today is 2.62.

Good Sign:

Alibaba Health Information Technology Ltd stock PB Ratio (=2.45) is close to 10-year low of 2.23.

The historical rank and industry rank for Alibaba Health Information Technology's PB Ratio or its related term are showing as below:

ALBHF' s PB Ratio Range Over the Past 10 Years
Min: 2.23   Med: 11.99   Max: 60.87
Current: 2.48

During the past 13 years, Alibaba Health Information Technology's highest PB Ratio was 60.87. The lowest was 2.23. And the median was 11.99.

ALBHF's PB Ratio is ranked worse than
58.72% of 608 companies
in the Healthcare Providers & Services industry
Industry Median: 1.975 vs ALBHF: 2.48

During the past 12 months, Alibaba Health Information Technology's average Book Value Per Share Growth Rate was 15.70% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -0.50% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -2.30% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 25.20% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Alibaba Health Information Technology was 66.40% per year. The lowest was -12.60% per year. And the median was 13.45% per year.

Back to Basics: PB Ratio


Alibaba Health Information Technology  (OTCPK:ALBHF) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Alibaba Health Information Technology PB Ratio Related Terms


Alibaba Health Information Technology PB Ratio Historical Data

* Premium members only.

The historical data trend for Alibaba Health Information Technology's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alibaba Health Information Technology PB Ratio Chart

Alibaba Health Information Technology Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.95 4.52 3.42 4.36 3.77

Alibaba Health Information Technology Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.42 4.93 4.36 5.51 3.77

Alibaba Health Information Technology PB Ratio Competitor Comparison

For the Pharmaceutical Retailers subindustry, Alibaba Health Information Technology's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alibaba Health Information Technology PB Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Alibaba Health Information Technology's PB Ratio distribution charts can be found below:

* The bar in red indicates where Alibaba Health Information Technology's PB Ratio falls into.


ALBHF
55GF Score
Alibaba Health Information Technology Ltd ALBHF
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alibaba Health Information Technology PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Alibaba Health Information Technology's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2026)
=0.42112/0.161
=2.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Frequently Asked Questions Learn more about PB Ratio →
What does a PB Ratio of 2.62 mean?
Alibaba Health Information Technology (ALBHF) has a PB Ratio of 2.62 as of Jul. 01, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Alibaba Health Information Technology and its competitors. This is 78% below median its historical median of 11.99. Over the past decade, Alibaba Health Information Technology's PB Ratio has ranged from 2.23 to 60.87. According to the industry distribution chart, Alibaba Health Information Technology ranks #357 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 58.7%.
Is Alibaba Health Information Technology's PB Ratio too high?
Alibaba Health Information Technology's current PB Ratio of 2.62 is 78% below median its 10-year median of 11.99. Over the past 10 years, this metric has ranged from a low of 2.23 to a high of 60.87. The Healthcare Providers & Services industry median PB Ratio is 1.98. Alibaba Health Information Technology's value of 2.62 is 32.7% above this industry median. Based on the distribution chart, Alibaba Health Information Technology ranks #357 out of 608 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Alibaba Health Information Technology has a GF Score™ of 55/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alibaba Health Information Technology's PB Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Alibaba Health Information Technology ranks #357 out of 608 companies for PB Ratio. This places Alibaba Health Information Technology in the lower half of its industry. The industry median PB Ratio is 1.98. Alibaba Health Information Technology's value of 2.62 is 32.7% above this benchmark. Historically, Alibaba Health Information Technology's own PB Ratio has ranged from 2.23 to 60.87 over the past decade. While the company's 10-year median is 11.99 vs. the industry median of 1.98, Alibaba Health Information Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.98, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alibaba Health Information Technology's current PB Ratio of 2.62 is 32.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Alibaba Health Information Technology and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alibaba Health Information Technology's current PB Ratio is 2.62, which is 78% below median its own 10-year median of 11.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alibaba Health Information Technology stock overvalued right now?
Based on GuruFocus' analysis, Alibaba Health Information Technology (ALBHF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.70, compared to a current price of $0.42 — trading 39.8% below its estimated fair value. The current PB Ratio is 2.62, which is 78% below median its 10-year median of 11.99 and 32.7% above the Healthcare Providers & Services industry median of 1.98. Alibaba Health Information Technology's overall GF Score™ is 55/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Alibaba Health Information Technology (ALBHF), the current PB Ratio is 2.62 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alibaba Health Information Technology (ALBHF) Overvalued in 2026?

Based on GuruFocus' analysis, Alibaba Health Information Technology stock appears to be undervalued. The current stock price of $0.42 is trading 39.8% below its estimated GF Value™ of $0.70. GuruFocus considers Alibaba Health Information Technology to be Significantly Undervalued.

Key valuation signals for ALBHF:

  • PB Ratio: 2.62 (78% below median its 10-year median of 11.99)
  • GF Value™: $0.70 vs. price of $0.42 (39.8% below fair value)
  • GF Score™: 55/100 with 2 warning signs
  • Industry Position: 32.7% above the Healthcare Providers & Services median (#357 of 608)

No single metric tells the full story. See the ALBHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alibaba Health Information Technology Business Description

Address Wangjing East Park, 30th Floor, Greenland Center, Building 9, Zone 4, Chaoyang District, Beijing, CHN
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
55GF Score

Get the complete analysis for ALBHF

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.42
Price
$0.70
GF Value